CMEDEarningsprnewswire

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Sentiment:Negative (30)

Summary

Enrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) with respiratory failure; data expected in early 2026 Productive initial meeting with the FDA on Auxora in acute pancreatitis (AP); conversations continue, with alignment on a pivotal trial anticipated...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 12, 2025 by prnewswire